Drug
Infective endocarditis in pregnant women without intravenous drug use: a multicentre retrospective case series
Objectives:
To describe the clinical features and outcomes of infective endocarditis (IE) in pregnant women who do not inject drugs....
The FDA weighs in on market research and drug developers are listening – especially to the underserved – PharmaLive
The FDA weighs in on market research and drug developers are listening – especially to the underserved
By Fabio Gratton
A new era of FDA guidance
T...
NIAID trial to test asthma drug in disadvantaged urban children
…according to the National Institute of Allergy and Infectious Diseases.
Black and Hispanic children who live in these environments are at pa...
Indigenous and drug policy groups try to preserve traditional approaches as psychedelic markets open up in Oregon
Indigenous medicine and drug policy groups join forces to form a new nonprofit. They want to promote and preserve the use of traditional medicines...
Racial Disparities Seen in US Food and Drug Administration Drug Approval Trials in Multiple Myeloma
According to the results of a study published in Blood Advances, Black and Hispanic patients appear to be underrepresented in global clinical trial...
Group works to get more people of color in clinical drug trials
Renita Raney has lung cancer. It’s her third cancer fight.”The doctor came in on my last visit with him and said there’s nothing ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
